Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)

Sebastian Dekkers1, Dehan Comez2,3, Noemi Karsai2,3

  • 1Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, United Kingdom.

PubMed
Summary

Researchers developed novel fluorescent probes targeting the atypical chemokine receptor 3 (ACKR3), a key driver of cancer progression. These probes enable detailed study of ACKR3